XML 58 R41.htm IDEA: XBRL DOCUMENT
v3.26.1

STOCKHOLDERS’ EQUITY (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Equity [Abstract] |
Schedule of assumptions |
Schedule of assumptions |  |  |
Company stock price on valuation date |  | $ | 10.00 |
Volatility |  |  | 143.85% |
Risk free interest rate - 5 years |  |  | 3.94% |
Risk free interest rate - 10 years |  |  | 4.43% |
Dividend yield |  |  | 0.00% |
Schedule of fair values and derived service periods |
Schedule of fair values and derived service periods |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Daily VWAP $10 |  |  | Daily VWAP $15 |  |  | Daily VWAP $20 |  |  | Daily VWAP $25 |  |  | Daily VWAP $30 |
Fair value - 5 year service period |  | $ | 9.03 |  |  | $ | 9.02 |  |  | $ | 9.02 |  |  | $ | 9.02 |  |  | $ | 9.01 |
Derived service period - years |  |  | N/A |  |  |  | 0.20 |  |  |  | 0.38 |  |  |  | 0.56 |  |  |  | 0.69 |
Fair value - 10 year service period |  | $ | 9.82 |  |  | $ | 9.80 |  |  | $ | 9.80 |  |  | $ | 9.80 |  |  | $ | 9.80 |
Derived service period - years |  |  | N/A |  |  |  | 0.20 |  |  |  | 0.40 |  |  |  | 0.58 |  |  |  | 0.73 |
Schedule of pre-funded common stock warrants |
Schedule of pre-funded common stock warrants |  |  |  |  |  |  |  |  |  |  |  |
|  | Pre- Funded Common Stock Warrants |
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Life in years(1) |  |  | Intrinsic Value |
Outstanding at January 1, 2025 |  |  | 10,263 |  |  | $ | 0.00064 |  |  |  |  |  |  |  |  |
Purchased |  |  | 6,429,237 |  |  | $ | 0.00002 |  |  |  |  |  |  |  |  |
Exercised |  |  | (2,525,962 | ) |  | $ | 0.00002 |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2025 |  |  | 3,913,538 |  |  | $ | 0.00002 |  |  |  | – |  |  | $ | 17,865,238 |
Exercisable at December 31, 2025 |  |  | 3,913,538 |  |  | $ | 0.00002 |  |  |  | – |  |  | $ | 17,865,238 |
| (1) | Pre-funded warrants expire only upon exercise
Schedule of warrants activity |
Schedule of warrants activity |  |  |  |  |  |  |  |  |  |  |  |
|  | Other Common Stock Warrants |
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Life in years |  |  | Intrinsic Value |
Outstanding at January 1, 2025 |  |  | 14,804 |  |  | $ | 4,158.33 |  |  |  |  |  |  |  |  |
Granted/purchased |  |  | 1,844,148 |  |  | $ | 12.42 |  |  |  |  |  |  |  |  |
Exercised |  |  | (123,603 | ) |  | $ | 14.43 |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2025 |  |  | 1,735,349 |  |  | $ | 47.66 |  |  |  | 6.98 |  |  | $ | – |
Exercisable at December 31, 2025 |  |  | 1,735,349 |  |  | $ | 47.66 |  |  |  | 6.98 |  |  | $ | – |

X
- References No definition available. + Details
Name: | EMPD_ScheduleOfPrefundedCommonStockWarrantsActivityTableTextBlock
Namespace Prefix: | EMPD_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 101 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (j) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-5 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (k) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_ScheduleOfAssumptionsUsedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration